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Abstract
Members of the carcinoembryonic antigen family (CEACAMs) are widely expressed, and,
depending on the tissue, capable of regulating diverse functions including tumor promotion, tumor
suppression, angiogenesis, and neutrophil activation. Four members of this family, CEACAM1,
CEACAM8, CEACAM6, and CEACAM3 (recognized by CD66a, CD66b, CD66c, and CD66d
mAbs, respectively), are expressed on human neutrophils. CD66a, CD66b, CD66c, and CD66d
antibodies each increase neutrophil adhesion to human umbilical vein endothelial cell monolayers.
This increase in neutrophil adhesion caused by CD66 antibodies is blocked by CD18 mAbs and is
associated with upregulation of CD11/CD18 on the neutrophil surface. To examine potential
interactions of CEACAMs in neutrophil signaling, the effects on neutrophil adhesion to human
umbilical vein endothelial cells of a set of CD66 mAbs was tested following desensitization to
stimulation by various combinations of these mAbs. Addition of a CD66 mAb in the absence of
calcium results in desensitization of neutrophils to stimulation by that CD66 mAb. The current data
show that desensitization of neutrophils to any two CEACAMs results in selective desensitization
to those two CEACAMs, while the cells remain responsive to the other two neutrophil CEACAMs.
In addition, cells desensitized to CEACAM-3, -6, and -8 were still responsive to stimulation of
CEACAM1 by CD66a mAbs. In contrast, desensitization of cells to CEACAM1 and any two of the
other CEACAMs left the cells unresponsive to all CD66 mAbs. Cells desensitized to any
combination of CEACAMs remained responsive to the unrelated control protein CD63. Thus,
while there is significant independence of the four neutrophil CEACAMs in signaling, CEACAM1
appears to play a unique role among the neutrophil CEACAMs. A model in which CEACAMs
dimerize to form signaling complexes could accommodate the observations. Similar interactions
may occur in other cells expressing CEACAMs.
Background
The carcinoembryonic antigen (CEA)2 family consists of
two subfamilies, the CEACAM subgroup and the preg-
nancy specific glycoprotein (PSG) subgroup. Members of
this family have been redundantly named [for review see
[1-4]], but subsequent consensus unified the nomencla-
ture for the CEACAM family [5]. CEACAM family mem-
bers are widely expressed in epithelial, endothelial, and
hematopoietic cells, including neutrophils, T-cells, and
NK cells. CEACAMs appear to be capable of transmitting
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signals that result in a variety of effects depending on the
tissue, including tumor suppression, tumor promotion,
angiogenesis, neutrophil activation, lymphocyte activa-
tion, regulation of the cell cycle, and regulation of adhe-
sion [2,3,5-42]. In many tissues, more than one CEACAM
family member are expressed concurrently. For example,
CEACAMs 1, 5, and 6 are often expressed in ovarian,
endometrial, cervical, breast, lung, and colon carcinomas,
and may be useful as biomarkers in cancer [43-47]. A
CEACAM5 expressing measles virus has entered phase I
trials in ovarian cancer [48]. CD66mAbs that recognize
CEACAMs are also in clinical trials as part of conditioning
regimens in allogeneic stem cell transplantation for acute
leukemia [49,50]
The CEACAM gene family contains more than seventeen
expressible closely related genes that belong to the immu-
noglobulin (Ig) gene superfamily [for review see
[1,2,4,5,22] and cea.klinikum.uni-muenchen.de]. Each of
the human CEACAM family molecules contains one
amino-terminal (N) domain of 108–110 amino acid resi-
dues homologous to Ig variable domains, followed by a
differing number of Ig constant-like domains. CD66
mAbs react with members of the CEACAM family. Clearly
characterized mAbs belonging to the CD66 cluster are
described by their reactivity with each family member as
indicated by a lower case letter after "CD66" as follows:
CD66a mAb, CEACAM1, biliary glycoprotein; CD66b
mAb, CEACAM8, CGM6; CD66c mAb, CEACAM6, NCA;
CD66d mAb, CEACAM3, CGM1; and CD66e mAb,
CEACAM5 or CEA [3]. CEACAM-1, -3, -6, and-8, but not
CEACAM-5 (CEA), are expressed on human neutrophils.
In humans, at least eight forms of CEACAM1, produced
by differential splicing of the single CEACAM1 gene, have
been identified [51-55]. In neutrophils, CEACAM1 and
CEACAM3 exist as transmembrane proteins with cyto-
plasmic tails, while CEACAM8 and CEACAM6 are linked
to the membrane via a glycosyl-phosphatidylinositol
anchor.
CD66 mAbs have been reported to activate neutrophils
[23,24,27,37,39-41]. By use of specific mAbs, each of the
CEACAM family members expressed on neutrophils,
CEACAM1, CEACAM8, CEACAM6, and CEACAM3 (rec-
ognized by CD66a, CD66b, CD66c, and CD66d mAbs,
respectively) have been shown to be capable of activating
neutrophils as determined by the physiologic response of
adhesion to human umbilical vein endothelial cells
(HUVECs) [37]. CD66 mAb binding to the neutrophil
surface triggers a transient activation signal that requires
extracellular calcium and regulates the adhesive activity of
CD11/CD18 [37]. In the absence of extracellular calcium,
this activation state decays and is no longer functional
after 10 min.
The similarity in structure among the CEACAMs, and their
ability to undergo homotypic and heterotypic interactions
with other members of the family, led us to question the
degree of interdependency of CEACAM signaling in neu-
trophils. To examine potential interactions among
CEACAM members in transmitting signals in neutrophils,
the effects of a set of well characterized CD66 mAbs on
neutrophil adhesion to HUVECs was studied. The ability
of combinations of CD66 mAbs, in the absence of cal-
cium, to desensitize neutrophils to subsequent simulation
by CD66 mAbs was examined. The data demonstrate sig-
nificant functional independence of the four CEACAM
molecules in signaling, but also suggest a unique role for
CEACAM-1 in CEACAM signaling in neutrophils.
Methods
Cell preparation
Normal peripheral blood neutrophils were prepared by a
modification of the method of Boyum as previously
described [56], and were suspended at the indicated con-
centrations in Hanks' balanced salt solution (HBSS) with
or without Ca2+ (Gibco, Grand Island, NY), as indicated.
Differential cell counts on Wright-stained cells routinely
revealed greater than 95% neutrophils. Viability as
assessed by trypan blue dye exclusion was greater than
98%.
Antibodies and reagents
The CD45 mAb AHN-12 (IgG1) [57], the CD63 mAb
AHN-16.1 (IgG1) [58], and the anti-HLA class I mAb W6/
32 (IgG2a) [59] have been previously described. CD66
mAbs were obtained from the CD66 section of the Sixth
International Workshop and Conference on Human Leu-
kocyte Differentiation Antigens and included the follow-
ing CD66 mAbs: B13.9 (IgG1) (CD66b), C11228.2C
(IgG1) (CD66c), Bu-104 (IgG1) (CD66ae), and COL-1
(IgG2a) (CD66de) [3].
The PE-labeled CD11b mAb (Leu 15) was obtained from
Becton Dickenson (Mountain View, CA). The source of
mAbs was either hybridoma cell culture supernatants,
purified antibody, or ascites fluid diluted in PBS contain-
ing 1 mg/ml BSA as indicated. All sera and ascites were
heat inactivated at 56°C for 30 min and clarified by cen-
trifugation at 13,000 × g at 4°C for 15 min before use. N-
formyl-met-leu-phe (FMLP) and normal mouse serum
(NMS) were purchased from Sigma Chemical Co. (St.
Louis, MO).
Fluorescence labeling of cells
Neutrophils were labeled with calcein AM (Molecular
Probes, Eugene, OR) [60] by incubating 5 × 106 cells/ml
with 50 ug of calcein AM for 30 min at 37°C in 18 ml of
calcein labeling buffer [HBSS without Ca2+ or Mg2+ con-
taining 0.02% BSA]. Cells were then washed twice withJournal of Translational Medicine 2008, 6:78 http://www.translational-medicine.com/content/6/1/78
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calcein labeling buffer at 23°C and resuspended in the
desired media.
Endothelial cell adhesion assay
Neutrophil adhesion to human umbilical vein endothe-
lial cells (HUVECs) was performed as previously
described [37]. Briefly, HUVECs (Clonetics Corp., San
Diego, CA) were passaged 1:5 in T-25 flasks (Costar) no
more than three times before plating in 96 well microtiter
plates at 3000 cells/well. HUVECs were grown to conflu-
ence in 96 well microtiter plates in EGM media (Clonet-
ics) and fed every 24 hours. Using the adhesion assay
described below, no difference in resting and stimulated
neutrophil adhesion was observed, and, as expected
[37,61], no difference in surface expression of CD54
(ICAM-1) or CD62E (E selectin, ELAM-1) in resting or
TNF stimulated cells was noted, using HUVECs passaged
once compared with those passaged five times. In some
experiments, the HUVECs were stimulated by culture for
4 hours at 37°C with 50 ng/ml TNFα (Cetus, Emeryville,
CA). The wells were then washed four times with calcium
free wash buffer (HBSS without Ca2+ plus 4% HIFBS) and
25 ul of calcium free wash buffer containing the indicated
antibody (10 ug/ml final concentration) was added to
each well. One hundred ul of calcium free wash buffer
containing 105  calcein-labeled neutrophils was added.
After the indicated time, 25 ul of calcium-free wash buffer
containing the indicated mAb (10 ug/ml final concentra-
tion) and 10.8 mM Ca2+ was then added to yield a final
physiologic calcium concentration (1.8 mM), and the
plates were incubated at 37°C in 5% CO2 for 30 min. The
wells were then aspirated and washed 4 times with endo
wash buffer (HBSS plus 4% HIFBS), and the fluorescence
was quantitated with a Millipore fluorescence plate reader
using an excitation wavelength of 485 nm and an emis-
sion wavelength of 530 nm. For each condition, quadru-
plicate wells were tested and values are reported as the
mean +/- SD. Each experiment was performed at least four
times using different HUVEC subcultures. The data in Fig-
ures 1 and 2 are shown as the percent of added neu-
trophils remaining adherent to the monolayers, and
represent the means +/- SD of 4 separate determinations.
While the SD is shown in each figure, in some panels it is
sufficiently small that it is not possible to see on the scale
shown.
Statistical analyses
Effects of mAbs on neutrophil adhesion to HUVECs was
analyzed by the Mann Whitney U test when appropriate.
Results
Effects of CD66 mAbs on neutrophil adhesion to 
endothelial cells
Because CEACAM-1, -3, -6, and -8 are highly homologous
structurally, and can undergo a number of different
homotypic and heterotypic adhesion reactions among
themselves [2,26,62-72], it is possible that they might
interact on the neutrophil surface. To better characterize
possible interactions among the CEACAMs in signaling
on human neutrophils, we utilized calcium-dependent
desensitization by CD66 mAbs to examine individual
CEACAM-mediated signaling. As expected, when neu-
trophils were incubated for 30 min with HUVECs and 10-
7 M FMLP in the presence of normal mouse IgG (IgG) or
mAb, and washed as described in the Methods, each of the
CD66ae, CD66b, CD66c, CD66de, and the control CD63
mAbs augmented neutrophil adhesion approximately
two-fold compared with IgG or media [not shown and
[37,58]]. In contrast, neither the CD45 mAb nor the anti-
HLA class I mAb altered neutrophil adhesion (not
shown).
Cross desensitization to pairs of CD66a, CD66b, CD66c, 
and CD66d mAbs
Desensitization of neutrophils to further stimulation by
mAbs directed to specific CEACAM family members by
exposure of the neutrophils to the mAbs in the absence of
calcium was used to examine the independence of signal-
ing mechanisms triggered by each CD66 mAb. Although
these CD66 mAbs stimulated neutrophil adhesion to rest-
ing HUVEC [37], for the experiments reported here, TNF-
treated HUVECs were used because these conditions
yielded a stronger signal in the assay. HUVECs were stim-
ulated for 4 hours with 50 ng/ml TNFα, washed, and neu-
trophils were added with desensitizing mAbs, incubated
in the absence of calcium, washed, and stimulated with
other mAbs and cell adhesion quantitated as described in
the Methods. First, IgG was added to the microtiter wells
containing the TNF stimulated HUVECs in the absence of
Ca2+ (Fig 1, panel A). As expected [37,58], when neu-
trophils were added to the wells in the absence of Ca2+ and
allowed to incubate for 15 sec before Ca2+ was added
(solid bars) stimulated neutrophil adhesion was observed
when aliquots of CD66ae mAb, CD66b mAb, CD66c,
CD66de, or CD63 mAbs were added, but not when buffer
was added. Since the CD66e antigen is not expressed in
neutrophils, the available CD66ae and CD66de mAbs can
be used effectively as CD66a and CD66d mAbs, respec-
tively, in this cell system. When neutrophils were added to
the wells in the absence of Ca2+ and allowed to incubate
for 15 min before Ca2+ was added (hatched bars), stimu-
lated neutrophil adhesion to the HUVECs following the
addition of aliquots of CD66ae, CD66b, CD66c, CD66de,
and CD63 mAbs, but not buffer was also observed.
Next, the CD66ae and CD66b mAbs were added to the
microtiter wells containing the TNF stimulated HUVECs
in the absence of Ca2+ (Fig 1, panel B). As expected, when
neutrophils were added to the wells in the absence of Ca2+
and allowed to incubate for 15 sec before Ca2+ was addedJournal of Translational Medicine 2008, 6:78 http://www.translational-medicine.com/content/6/1/78
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Cross desensitization with two CD66 mAbs to further stimulation of neutrophil adhesion to HUVECs Figure 1
Cross desensitization with two CD66 mAbs to further stimulation of neutrophil adhesion to HUVECs. TNF-stimulated 
HUVECs were washed, and Ca2+ free buffer containing IgG (panel A), the CD66ae mAb and CD66b mAb (panel B), the 
CD66ae mAb and CD66c mAb (panel C), the CD66ae mAb and CD66de mAb (panel D), the CD66b mAb and CD66c mAb 
(panel E), the CD66b mAb and CD66de mAb (panel F), or the CD66c mAb and CD66de mAb (panel G), were added (see 
Methods). Neutrophils in Ca2+ free buffer were then added. After 15 sec (solid bars) or 15 min (hatched bars), the indicated 
next mAb or buffer, and Ca2+ (1.8 mM final concentration) were added. After 30 min the wells were washed. The * > (Panel A) 
indicates the amount of adhesion observed when neutrophils were incubated in the wells for 30 min in the presence of buffer 
containing Ca2+ with or without 10 ug/ml IgG (final concentration). The percent of neutrophils adherent to the monolayers are 
shown. Selective desensitization at 15 min was statistically significant (p < 0.05).Journal of Translational Medicine 2008, 6:78 http://www.translational-medicine.com/content/6/1/78
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Cross desensitization with three CD66 mAbs to further stimulation of neutrophil adhesion to HUVECs Figure 2
Cross desensitization with three CD66 mAbs to further stimulation of neutrophil adhesion to HUVECs. TNF-stimulated 
HUVECs were washed and Ca2+ free buffer containing 10 ug/ml final concentration each of IgG (panel A), the CD66ae mAb, 
CD66b mAb, and CD66c mAb (panel B), the CD66ae mAb, CD66b mAb, and CD66de mAb (panel C), the CD66ae mAb, 
CD66c mAb, and CD66de mAb (panel D), or the CD66b mAb, CD66c mAb, and CD66de mAb (panel E), were added (see 
Methods). Neutrophils in Ca2+ free buffer were then added. After 15 sec (solid bars) or 15 min (hatched bars), buffer contain-
ing 10 ug/ml final concentration of the indicated next mAb or buffer, and Ca2+ (1.8 mM final concentration) were added. After 
30 min the wells were washed. The * > (panel A) indicates the amount of adhesion observed when neutrophils were incubated 
for 30 min in the presence of buffer containing Ca2+ with or without 10 ug/ml IgG (final concentration). The percent of neu-
trophils remaining adherent are shown. Selective desensitization at 15 min was statistically significant (p < 0.05).Journal of Translational Medicine 2008, 6:78 http://www.translational-medicine.com/content/6/1/78
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(solid bars) stimulated neutrophil adhesion was observed
when aliquots of buffer, CD66ae mAb, or CD66b mAb,
were added. Adhesion was also observed when aliquots of
CD66c mAb, CD66de mAb, or CD63 mAb were added.
When neutrophils were added to the wells in the absence
of Ca2+ and allowed to incubate for 15 min before Ca2+
was added (hatched bars), there was a marked decrease in
neutrophil adhesion to the HUVECs following the addi-
tion of aliquots of buffer, CD66ae mAb, or CD66b mAb.
In contrast, the cells were still responsive to stimulation
by CD66c, CD66de, and CD63 mAbs as evidenced by an
increase in adhesion.
Similarly, desensitization of neutrophils to stimulation by
the CD66ae and CD66c mAbs selectively desensitized the
cells to further stimulation by the CD66ae mAb and the
CD66c mAb, but not by CD66b, CD66de, or CD63 mAbs
(Fig 1, panel C). Finally, desensitization to the CD66ae
and CD66de mAbs left the cells unresponsive to CD66ae
and CD66de mAbs, but they remained responsive to
CD66b, CD66c, and CD63 mAbs (Fig 1, panel D).
When cells were desensitized to CD66b and CD66c mAbs,
the cells were unresponsive to CD66b and CD66c mAbs,
but were still responsive to stimulation by CD66ae,
CD66de, and CD63 mAbs as evidenced by an increase in
adhesion (Fig 1, panel E). Similarly, desensitization of
neutrophils to stimulation by the CD66b and CD66de
mAbs selectively desensitized the cells to further stimula-
tion by the CD66b and CD66de mAbs, but not by
CD66ae, CD66c, or CD63 mAbs (Fig 1, panel F). Similar
selectivity of this desensitization was observed when cells
were desensitized with the CD66c mAb and the CD66de
mAb, in that the cells were desensitized to CD66c and
CD66de mAbs, but not to CD66ae, CD66b, or CD63
mAbs (Fig 1, panel G).
Cross desensitization to combinations of three CD66 mAbs
Desensitization with various combinations of three CD66
mAbs was next examined. First, IgG was added to the
microtiter wells containing the TNF stimulated HUVECs
in the absence of Ca2+ (Fig 2, panel A). As expected, when
neutrophils were added to the wells in the absence of Ca2+
and allowed to incubate for 15 sec (solid bars) or 15 min
(hatched bars) before Ca2+ was added, stimulated neu-
trophil adhesion was similar to that observed in Figure 1,
panel A. Next, the CD66ae, CD66b, and CD66c mAbs
were added to the microtiter wells containing the TNF
stimulated HUVECs in the absence of Ca2+ (Fig 2, panel
B). As expected, when neutrophils were added to the wells
in the absence of Ca2+ and allowed to incubate for 15 sec
before Ca2+ was added (solid bars), stimulated neutrophil
adhesion was observed when aliquots of buffer, CD66ae
mAb, CD66b mAb, CD66c mAb, CD66de mAb, or CD63
mAb were added. When neutrophils were added to the
wells in the absence of Ca2+ and allowed to incubate for
15 min before Ca2+ was added (hatched bars), there was a
marked decrease in neutrophil adhesion to the HUVECs
following the addition of aliquots of buffer, CD66ae
mAb, CD66b mAb, or CD66c mAb. In addition, the cells
were no longer responsive to stimulation by the CD66de
mAb. In contrast, the cells were still responsive to stimu-
lation by CD63 mAbs as evidenced by an increase in adhe-
sion. Thus, cells were desensitized to CD66de mAb
stimulation with a combination of mAbs that does not
bind the CD66d antigen. Similarly, desensitization of
neutrophils to stimulation by the CD66ae, CD66b, and
CD66de mAbs desensitized the cells to further stimula-
tion by the CD66c mAb, as well as CD66ae, CD66b, and
CD66de mAbs, but not by CD63 mAbs (Fig 2, panel C).
Similar selectivity of this desensitization was observed
when cells were desensitized with the CD66ae, CD66c,
and CD66de mAbs, in that the cells were desensitized to
CD66ae, CD66b, CD66c, and CD66de mAbs, but not to
CD63 mAbs (Fig 2, panel D). In contrast, desensitization
to the CD66b, CD66c, and CD66de mAbs left the cells
unresponsive to CD66b, CD66c, and CD66de mAbs, but
they remained responsive to both CD66ae and CD63
mAbs (Fig 2, panel E).
Discussion
While it has been shown that CEACAM-1, -8, -6, and -3
can each independently transduce signals in neutrophils
resulting in activation of CD11/CD18, and an increase in
neutrophil adhesion to endothelial cells [37], potential
interactions among these molecules in neutrophil activa-
tion are not well defined. Experiments in which CD66
mAbs were allowed to bind to the neutrophils for various
lengths of time in the absence of calcium before calcium
repletion, suggested that the binding of CD66 mAbs to
the neutrophil surface results in a transient activation state
during which time a signal can be transmitted to CD11/
CD18 if extracellular calcium is present. In the absence of
extracellular calcium, this activation state decayed signifi-
cantly within 1 min, and is no longer functional after 10
min, i.e. the cell is desensitized to stimulation by that
mAb [37]. This observation allowed the current study to
be performed.
This study demonstrates that desensitization of neu-
trophils to stimulation by any two neutrophil CEACAMs
allows the cell to respond to stimulation by the other two
neutrophil CEACAMs. However, neutrophils desensitized
to CEACAM-1 and any other two neutrophil CEACAMs,
are unresponsive to the remaining neutrophil CEACAM,
while retaining responsiveness to the unrelated mem-
brane protein CD63. In contrast, neutrophils desensitized
to CEACAM-8, -6, and -3, were still responsive to both
CEACAM-1 and CD63. Thus, CEACAM-1 appears to have
a unique role in CEACAM signaling in neutrophils.Journal of Translational Medicine 2008, 6:78 http://www.translational-medicine.com/content/6/1/78
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We feel the observed results are due to mAbs binding their
specific antigens on the neutrophil surface. There are
potential alternative explanations for the results observed
in this study. CEACAM1 can be expressed on HUVECs.
Therefore, in earlier studies, a series of experiments
addressed the possibility that the observed results could
be due to CD66 mAb binding the HUVECs [37]. Preincu-
bation of HUVECs with mAb under various conditions,
followed by washing, indicated that the effects of CD66
mAbs were due to mAbs binding to the neutrophils and
not the HUVECs [37].
Furthermore, it was also possible that the Fc fragments of
these mAbs could alter signaling. The CD66 mAbs used
here could also induce a conformational change in a
CEACAM, or possibly cluster surface CEACAMs. These
possibilities were addressed in an earlier report in which
F(ab')2 fragments of the CD66ae, CD66be, and CD66c
mAbs were found to stimulate neutrophil adhesion to
HUVECs in this assay, as did the intact IgGs [37]. In con-
trast, Fab fragments of the CD66ae mAb had little effect
on neutrophil adhesion in this assay, suggesting that
cross-linking or clustering of CEACAMs could play a role
in the observed effects [37].
The molecular explanation for these observations is
unclear. CD66b and CD66c mAbs triggered an activation
signal, despite the fact that they bind GPI-linked surface
proteins, as has been previously reported [37]. MAb bind-
ing to other GPI-liniked proteins can also transduce sig-
nals [27]. While the details of the "activation signal"
transmitted by CEACAMs are not known, the finding of
tyrosine kinase activity, including lyn and hck, associated
with CEACAM-1, CEACAM-6, and CEACAM-8, and src
with CEACAM-1, suggests that these kinase activities may
be involved in signal transduction via CEACAM family
members [73,74]. CEACAM1 is also associated with pro-
tein tyrosine phosphatase activity [75]. CEACAM1 in neu-
trophils also undergoes transient changes in
phosphorylation following stimulation with chemotactic
agents, suggesting that phosphorylation may be involved
in regulating CEACAM-1 function as well [73,74].
CEACAM3 is tyrosine phosphorylated upon binding
gonococci expressing CEACAM ligand Opa protein vari-
ants [76]. Tyrosine kinase activity in neutrophils has also
been reported to be associated with CD63, the control sig-
naling molecule used in this study [58], while serine
kinase activity has been reported to associate with CD63
in melanoma cells [77].
Although mAbs to both CEACAM1 and CEACAM3 trig-
gered neutrophil activation in this study, the cytoplasmic
domain of CEACAM1 has an ITIM motif, while that of
CEACAM3 contains an ITAM sequence. In a transfected
HeLa epithelial cell model, uptake of gonococci mediated
by CEACAM1 and CEACAM3 differed with regard to their
sensitivity to tyrosine kinase inhibitors [78]. Other studies
have also found differences in the mechanism of
CEACAM3 and CEACAM6 mediated uptake; the former
being dependent on tyrosine kinase activity and the latter
requiring the integritiy of cholesterol-rich membrane
microdomains [79,80].
The data are consistent with the existence of signaling
complexes containing more than one CEACAM on the
neutrophil surface. CEACAMs have been shown to
undergo homotypic and heterotypic adhesion [55,62,65-
67,70-72,81-83]. CEACAM8 exhibits heterotypic adhe-
sion with CEACAM6, while CEACAM-1, -6, and -5 exhibit
both homotypic and heterotypic adhesion. For example, a
model in which CEACAMs exist as heterodimers contain-
ing two different CEACAMs or CEACAM-1-CEACAM-1
homodimers in a signaling complex, in which an active
CEACAM dimer is required for signal transmission, could
explain the current observations (Fig 3). For example, in
this model, desensitization of CEACAM-1 would allow
signaling by CEACAM-8/6; 8/3; or 6/3 dimers, while
desensitization of CEACAM-1 and any other two
CEACAMs would leave no active dimers. In contrast,
desensitization of CEACAMs-8, 6, and 3 would leave
active CEACAM-1 homodimers. Association of CEACAMs
into larger complexes containing more than just two
CEACAMs is also possible. Data have been reported show-
ing that CEACAM-1 can form dimers in solution and on
an epithelial cell surface [84]. Dr. Singer and colleagues
have provided evidence that complex formation among
CEACAMs in neutrophils is possible [35,85]. Despite hav-
ing tried a number of experimental approaches, including
immunoprecipitation, immunoblotting, and surface labe-
ling with 125I and biotin, we have not been able to detect
the existence of such complexes in neutrophils (data not
shown). Given the convergence of signaling by the differ-
ent CEACAMs with different cytoplasmic domains, it is
possible that another molecule may act as an intermediary
in CEACAM signaling.
The role(s) of CEACAMs in neutrophil function are com-
plex. However, ligation of CEACAM-1, -8, -6, and -3 by
CD66a, CD66b, CD66c, and CD66d mAbs, respectively,
transduce signals in neutrophils resulting in activation of
CD11/CD18, and an increase in neutrophil adhesion to
endothelial cells, one of the critical first steps of inflam-
mation [37]. In addition, several other reports have also
suggested that CEACAMs are capable of regulating the
function of CD11/CD18 [24,39,40], and induce an
increase in intracytoplasmic calcium and an oxidative
burst in neutrophils [27]. CEACAM1 also regulates neu-
trophil apoptosis, thus possibly influencing the resolu-
tion of inflammation [34]. Finally, studies have shown
that certain bacteria bind to some CEACAM family mem-Journal of Translational Medicine 2008, 6:78 http://www.translational-medicine.com/content/6/1/78
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bers on neutrophils, and this interaction may also result
in signal transduction resulting in modification of neu-
trophil activity [6,8,22,86-96]. Thus, CEACAMs appear to
be involved in neutrophil adhesion by transmitting some
form of activation signal that regulates the activity of other
adhesion molecules, as well as possibly by homotypic or
heterotypic adhesion. CEACAMs-1, -8, and -6, are upregu-
lated to the neutrophil surface from intracellular stores
following stimulation [97-99].
The current observations may also be relevant to other
cells expressing CEACAMs. CEACAM1 and CEACAM6
have been reported to present selectin ligands to CD62E
(ELAM-1, E-selectin) on endothelial cells [23], and appear
to be involved in angiogenesis [9,16,28,100]. A role for a
soluble form of CEACAM1 in angiogenesis has also been
demonstrated [100]. CEACAM1 also appears to play a
critical role in tumor lymphangiogenesis [15], and can
regulate cell migration via interaction with filamin A [17].
CEACAM1 associates with the beta 3-integrin, and this
association is dependent on the phosphorylation of Tyr-
488 in the cytoplasmic domain of CEACAM1; this com-
plex may play a role in cell invasion [101]. During cell-
matrix adhesion of endothelial cells, CEACAM1 associates
with talin, a regulator of integrin function [28]. CEACAMs
serve as a receptor for murine hepatitis virus [102-106],
and as a human receptor for Neisseria meningiditis and
Neisseria gonorrhea [8,22,86-91,94,95]. CEACAMs can
Model of potential CEACAM dimers in signaling complexes on neutrophils Figure 3
Model of potential CEACAM dimers in signaling complexes on neutrophils. A possible model of CEACAM signaling complexes 
on neutrophils that is compatible with observed desensitization data is shown. In this model, CEACAMs can exist on the neu-
trophil surface as heterodimers or as CEACAM-1 homodimers. Signaling would require an active dimer. For example, desensi-
tization of CEACAM-1 would allow signaling by CEACAM-8/6; 8/3; or 6/3 dimers, while desensitization of CEACAM-1 and any 
other two CEACAMs would leave no active dimers. In contrast, desensitization of CEACAMs-8, 6, and 3 would leave active 
CEACAM-1 homodimers. The existence of potential unidentified cooperative signaling molecules is denoted by the "?"Journal of Translational Medicine 2008, 6:78 http://www.translational-medicine.com/content/6/1/78
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also transmit signals regulating proliferation of epithelial
cells and lymphocytes [2,6-8,13,14,22,35,36,107,108].
Thus, interactions among CEACAMs in signaling may
occur in various cell systems.
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